Skip to content
★ Sign in to follow
노브

노브메타파마 Stock: price and insider trades · South Korea

No insider purchase over the last 90 days. The latest, by 송문진, was filed 05 Feb 2026.

노브메타파마: what insiders have been doing

노브메타파마, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). Over the twelve months to 10 November 2026, 2 filings were filed, from 2 insiders.

On the market, 1 insider bought (1 purchase) while 1 insider sold (1 sale). No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The most recent open-market purchase was published on 5 February 2026, 278 days ago.

With 2 filings in twelve months, the company is quieter than the median of 7 filings across the 2,648 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 8 purchases and 15 sales.

In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
27
Thresholds
n/a
Buy Volume
n/a
8 ops. · all time
Sell Volume
n/a
15 ops. · all time

Who traded when

BuySale
송문진1 buy
황선욱1 sale

Financial data

· cache

Last declaration on 5 February 2026
Declarations27 total
  • ▼
    Executives
    0DART
    1,062,309 sharesKRXDART:20260205000578
  • ▲
    Executives
    0DART
    42,788 sharesKRXDART:20260205000600
    Canonical exit: 6 May 2026 (T+90)
  • ▼
    Executives
    0DART
    6,500 sharesKRXDART:20241115000302
  • ▼
    Executives
    0DART
    407,226 sharesKRXDART:20241115000299
  • ▼
    Executives
    0DART
    30,000 sharesShareKRXDART:20230706000398
  • ▼
    Executives
    0DART
    407,226 sharesKRXDART:20230706000431
  • ▼
    Executives
    0DART
    407,226 sharesKRXDART:20230706000421
  • ▼
    Executives(filed)
    0DART
    407,226 sharesKRXDART:20230331004014
  • ▼
    Executives(filed)
    0DART
    407,226 sharesKRXDART:20230331004055
  • ▼
    Executives
    0DART
    1,500 sharesShareKRXDART:20221209000560
  • ▼
    Executives(filed)
    0DART
    407,226 sharesKRXDART:20221004000290
  • ▼
    Executives(filed)
    0DART
    407,226 sharesKRXDART:20221004000286
  • ▲
    Executives(filed)
    0DART
    1,205,098 sharesKRXDART:20220405002315
    Canonical exit: 4 Jul 2022 (T+90)
  • ▲
    Executives
    0DART
    13,279 sharesShareKRXDART:20220405002117
    Canonical exit: 29 Jun 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    147,295 sharesKRXDART:20220405002366
    Canonical exit: 4 Jul 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    25,964 sharesKRXDART:20220318000652
    Canonical exit: 16 Jun 2022 (T+90)
  • ▲
    Executives
    0DART
    2,858 sharesShareKRXDART:20220318000708
    Canonical exit: 9 Jun 2021 (T+90)
  • ▲
    Executives
    0DART
    4,049 sharesShareKRXDART:20220318000697
    Canonical exit: 9 Jun 2021 (T+90)
  • ▲
    Executives
    0DART
    4,764 sharesShareKRXDART:20220318000682
    Canonical exit: 9 Jun 2021 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Executives(filed)
    0DART
    407,226 sharesKRXDART:20211231000163
  • ▼
    Executives(filed)
    0DART
    407,226 sharesKRXDART:20210706000360
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Executives(filed)
    0DART
    407,226 sharesKRXDART:20210401002435
  • ●
    Executives
    Executives(filed)
    0DART

25 of 27 declarations

About 노브메타파마

Nobmeta Pharma is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of innovative treatments and therapeutic solutions.